Beanguard Gargle Plus

Description

Beanguard Gargle Plus is a gargle solution formulated with Benzalkonium Chloride as the active ingredient at a concentration of 0.1%. The formulation includes several inactive ingredients: Citric Acid, Glycerin, Menthol, Purified Water, Sodium Benzoate, Sodium Citrate, Sorbitol, Sucralose, and Flavoring. This combination of components contributes to the overall efficacy and sensory profile of the product.

Uses and Indications

This drug is indicated for the prevention of dental cavities. Additionally, it aids in refreshing breath.

Dosage and Administration

Healthcare professionals should instruct patients to vigorously swish 10 mL of the gargle solution between their teeth for a duration of 1 minute. Following this, the solution should be expectorated and not swallowed. It is essential to emphasize the importance of not swallowing the gargle to ensure safety and efficacy.

Contraindications

There are no specified contraindications for this product. However, it is advised not to use more than directed or for a longer duration than recommended.

In the event of oral irritation or tooth sensitivity, discontinue use and consult a dentist.

Warnings and Precautions

It is imperative that this product is not swallowed. To ensure safety, it should be kept out of reach of children under 6 years of age. Healthcare professionals should advise patients to adhere strictly to the recommended dosage and duration of use; exceeding these guidelines is not advised.

In the event of oral irritation or tooth sensitivity, patients are instructed to discontinue use and consult a dentist for further evaluation.

This product contains fluorine, which necessitates caution. If an individual accidentally swallows more than the amount intended for rinsing, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of this product. Serious reactions may include oral irritation and tooth sensitivity. In the event that these symptoms occur, patients are advised to discontinue use and consult a dentist for further evaluation.

It is important to note that the product should not be swallowed. Adherence to this warning is crucial to prevent any serious complications.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Beanguard Gargle Plus (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 6 years of age should not have access to this medication, as it is not indicated for use in this age group. Caregivers must ensure that the product is stored safely and out of reach of young children to prevent accidental ingestion.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

There is currently no information available regarding the use of Beanguard Gargle Plus during pregnancy, including safety concerns, dosage modifications, or any special precautions that should be taken. Healthcare professionals are advised to exercise caution when prescribing this medication to pregnant patients, as the lack of data precludes a comprehensive assessment of potential risks to fetal outcomes. Women of childbearing potential should be informed of this uncertainty and encouraged to discuss any concerns with their healthcare provider.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. The effects on breastfed infants have not been established, and further data may be necessary to inform clinical decisions.

Renal Impairment

Patients with renal impairment may require dosage adjustments to ensure safety and efficacy. It is essential to monitor renal function tests in individuals with reduced kidney function. Additionally, a reduced dose should be considered for patients with a creatinine clearance below a specified threshold to mitigate the risk of adverse effects.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement standard supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If available, specific antidotes or treatments should be administered as indicated based on the clinical scenario and the substance involved. Continuous assessment and supportive care are critical in managing the patient's condition effectively.

Healthcare professionals are encouraged to report any cases of overdose to the appropriate regulatory authorities and to consult poison control centers for additional guidance on management strategies.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are provided in the insert for BEANGUARD GARGLE PLUS (sodium fluoride liquid).

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children under 6 years of age to prevent accidental ingestion. It is important to instruct patients not to use the product in greater amounts or for longer than directed, as misuse can lead to adverse effects.

Patients should be informed to stop using the product and consult a dentist if they experience any oral irritation or tooth sensitivity. Additionally, since this product contains fluorine, healthcare providers should emphasize the importance of seeking medical help or contacting a Poison Control Center immediately if more than the recommended amount is accidentally swallowed.

Storage and Handling

The product is supplied in an airtight container and should be stored at room temperature, within a temperature range of 1 to 30 degrees Celsius. It is essential to ensure that the container remains sealed to maintain the integrity of the product.

Additional Clinical Information

The product is administered via the dental route. Patients are instructed to vigorously swish 10 mL of the gargle between their teeth for 1 minute before spitting it out, with a clear warning not to swallow the solution.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Beanguard Gargle Plus, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)